Skip to main content
Top
Published in: International Orthopaedics 11/2017

01-11-2017 | Original Paper

Subtypes of endothelial progenitor cells affect healing of segmental bone defects differently

Authors: Erica M. Giles, Charles Godbout, Wendy Chi, Michael A. Glick, Tony Lin, Ru Li, Emil H. Schemitsch, Aaron Nauth

Published in: International Orthopaedics | Issue 11/2017

Login to get access

Abstract

Purpose

Treating fracture nonunion with endothelial progenitor cells (EPCs) is a promising approach. Nevertheless, the effect of different EPC-related cell populations remains unclear. In this study, we compared the therapeutic potential of early (E-EPCs) and late EPCs (L-EPCs).

Methods

Male Fischer 344 rats were used for cell isolation and in vivo experiments. Bone marrow-derived E-EPCs and L-EPCs were kept in culture for seven to ten days and four weeks, respectively. For each treatment group, we seeded one million cells on a gelatin scaffold before implantation in a segmental defect created in a rat femur; control animals received a cell-free scaffold. Bone healing was monitored via radiographs for up to ten weeks after surgery. In vitro, secretion of vascular endothelial growth factor (VEGF) and bone morphogenetic protein (BMP)-2 was quantified by ELISA for both cell populations. Tube formation assays were also performed.

Results

Final radiographs showed complete (four out of five rats) or partial (one out of five rats) union with E-EPC treatment. In contrast, complete healing was achieved in only one of five animals after L-EPC implantation, while control treatment resulted in nonunion in all animals. In vitro, E-EPCs released more VEGF, but less BMP-2 than L-EPCs. In addition, L-EPCs formed longer and more mature tubules on basement membrane matrix than E-EPCs. However, co-culture with primary osteoblasts stimulated tubulogenesis of E-EPCs while inhibiting that of L-EPCs.

Conclusions

We demonstrated that bone marrow-derived E-EPCs are a better alternative than L-EPCs for treatment of nonunion. We hypothesize that the expression profile of E-EPCs and their adaptation to the local environment contribute to superior bone healing.
Literature
7.
go back to reference Medina RJ, O’Neill CL, Sweeney M, Guduric-Fuchs J, Gardiner TA, Simpson DA, Stitt AW (2010) Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC Med Genet 3:18. https://doi.org/10.1186/1755-8794-3-18 Medina RJ, O’Neill CL, Sweeney M, Guduric-Fuchs J, Gardiner TA, Simpson DA, Stitt AW (2010) Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC Med Genet 3:18. https://​doi.​org/​10.​1186/​1755-8794-3-18
10.
18.
go back to reference Bouletreau PJ, Warren SM, Spector JA, Peled ZM, Gerrets RP, Greenwald JA, Longaker MT (2002) Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast Reconstr Surg 109(7):2384–2397CrossRefPubMed Bouletreau PJ, Warren SM, Spector JA, Peled ZM, Gerrets RP, Greenwald JA, Longaker MT (2002) Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast Reconstr Surg 109(7):2384–2397CrossRefPubMed
Metadata
Title
Subtypes of endothelial progenitor cells affect healing of segmental bone defects differently
Authors
Erica M. Giles
Charles Godbout
Wendy Chi
Michael A. Glick
Tony Lin
Ru Li
Emil H. Schemitsch
Aaron Nauth
Publication date
01-11-2017
Publisher
Springer Berlin Heidelberg
Published in
International Orthopaedics / Issue 11/2017
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-017-3613-0

Other articles of this Issue 11/2017

International Orthopaedics 11/2017 Go to the issue